1.2 billion patients worldwide provided with medical care by Novartis.
Seventeen major approvals achieved including FDA approval for Dailies Total1, the industry's first water-gradient silicone hydrogel contact lens, and Flucelvax, the first cell-culture vaccine in the US to help protect against seasonal influenza.
Fougera Pharmaceuticals Inc. acquired by Sandoz, making the division the number one generic dermatology medicines company in the US and globally.
More than 100 million patients reached through access-to-healthcare programs valued at USD 2 billion.